miR-101 is a target of NEAT1 in breast cancer cells and Enhancer of Zeste 2 Polycomb Repressive Complex 2 Subunit (EZH2) was identified as a downstream target of miR-101. This evidence concerns the gene NEAT1 and breast cancer.